Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MM7G
|
|||
| Former ID |
DNC008629
|
|||
| Drug Name |
1-((9H-Fluoren-2-yl)methyl)-1H-imidazole
|
|||
| Synonyms |
CHEMBL502542; 1-((9H-Fluoren-2-yl)methyl)-1H-imidazole; SCHEMBL8607720
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H14N2
|
|||
| Canonical SMILES |
C1C2=CC=CC=C2C3=C1C=C(C=C3)CN4C=CN=C4
|
|||
| InChI |
1S/C17H14N2/c1-2-4-16-14(3-1)10-15-9-13(5-6-17(15)16)11-19-8-7-18-12-19/h1-9,12H,10-11H2
|
|||
| InChIKey |
OLHTVPMFDRPUTG-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Steroid 17-alpha-monooxygenase (S17AH) | Target Info | Inhibitor | [1] |
| BioCyc | Superpathway of steroid hormone biosynthesis | |||
| Glucocorticoid biosynthesis | ||||
| Androgen biosynthesis | ||||
| KEGG Pathway | Steroid hormone biosynthesis | |||
| Metabolic pathways | ||||
| Ovarian steroidogenesis | ||||
| Prolactin signaling pathway | ||||
| Pathwhiz Pathway | Androgen and Estrogen Metabolism | |||
| Steroidogenesis | ||||
| Reactome | Androgen biosynthesis | |||
| Glucocorticoid biosynthesis | ||||
| Endogenous sterols | ||||
| WikiPathways | Metapathway biotransformation | |||
| Steroid Biosynthesis | ||||
| Oxidation by Cytochrome P450 | ||||
| Metabolism of steroid hormones and vitamin D | ||||
| Glucocorticoid & Mineralcorticoid Metabolism | ||||
| Prostate Cancer | ||||
| Phase 1 - Functionalization of compounds | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis, biological evaluation, and molecular modeling studies of methylene imidazole substituted biaryls as inhibitors of human 17alpha-hydroxyl... Bioorg Med Chem. 2008 Aug 15;16(16):7715-27. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.